Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Change in Acquisitions & Divestments (2022 - 2026)

MoonLake Immunotherapeutics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $59.2 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 59.15% to $59.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $382.7 million through Mar 2026, up 65.75% year-over-year, with the annual reading at $468.4 million for FY2025, 222.58% up from the prior year.
  • Change in Acquisitions & Divestments came in at $59.2 million for Q1 2026, up from $29.3 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $205.9 million in Q2 2025 to a low of -$1.3 million in Q2 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $44.2 million (2024), against an average of $59.5 million.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 110.26% in 2024 and then skyrocketed 15927.29% in 2025.
  • MoonLake Immunotherapeutics' Change in Acquisitions & Divestments stood at $9.9 million in 2022, then skyrocketed by 1083.17% to $117.2 million in 2023, then tumbled by 100.18% to -$211000.0 in 2024, then skyrocketed by 13965.4% to $29.3 million in 2025, then skyrocketed by 102.24% to $59.2 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Change in Acquisitions & Divestments are $59.2 million (Q1 2026), $29.3 million (Q4 2025), and $88.4 million (Q3 2025).